Records containing: Recurrent Adult Primary Liver Cancer

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2025-04-11
PET/CT-Derived Hepatopulmonary Shunt Fraction Following Yttrium-90 Radioembolization
CLINICAL_TRIALS study record update · 2024-01-16
Intrinsic Dosimetry for Radioembolization Utilizing PET-CT Imaging Data: A Prospective Registry Study
CLINICAL_TRIALS study record update · 2023-12-14
A Phase II Randomized Multicenter Placebo-Controlled Blinded Study of Sorafenib Adjuvant Therapy in High Risk Orthotopic Liver Transplant (OLT) Recipients With Hepatocellular Carcinoma (HCC)
CLINICAL_TRIALS study record update · 2023-07-03
Randomized Phase III Study of Sorafenib Versus Stereotactic Body Radiation Therapy Followed by Sorafenib in Hepatocellular Carcinoma
CLINICAL_TRIALS study record update · 2022-09-30
A Humanitarian Device Exemption Treatment Protocol of TheraSphere® For Treatment of Unresectable Hepatocellular Carcinoma
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2019-05-15
A Pilot Open-Label Clinical Trial of CPI-613 in Patients With Advanced Bile Duct Cancers
CLINICAL_TRIALS study record update · 2017-09-26
A Phase I/II Study of PXD101 in Patients With Unresectable Hepatocellular Carcinoma With Pharmacokinetic and Pharmacodynamic Evaluation
CLINICAL_TRIALS study record update · 2017-06-14
Phase II and Pharmacodynamic Study of PS-341 in Patients With Unresectable or Metastatic Adenocarcinoma of the Bile Duct or Gallbladder
CLINICAL_TRIALS study record update · 2017-06-01
The CapSul Trial: A Phase II Study of Sunitinib and Capecitabine for the Treatment of Unresectable or Metastatic Hepatocellular Carcinoma (HCC)
CLINICAL_TRIALS study record update · 2017-03-29
A Phase 2 Study of AZD2171 (Cediranib) With Modified FOLFOX6 in Patients With Advanced Biliary Cancers
CLINICAL_TRIALS study record update · 2016-10-31
A Phase II Study of AZD2171 in Hepatocellular Carcinoma
CLINICAL_TRIALS study record update · 2016-02-29
Bevacizumab (RhuMAB-VEGF) In Hepatocellular Cancer For Patients With Unresectable Tumor (Without Invasion Of The Main Portal Vein Or Metastatic Disease) A Phase II Study
CLINICAL_TRIALS study record update · 2015-09-30
A Phase I Clinical and Biological Evaluation of Combined EGFR Blockade With Erlotinib and Cetuximab in Patients With Advanced Cancer
CLINICAL_TRIALS study record update · 2015-04-29
A Phase II Study of Efficacy and Tolerability of GW572016 in Patients With Advanced Hepatocellular and Biliary Carcinomas
CLINICAL_TRIALS study record update · 2015-03-27
Phase I Adjuvant Trial of Sorafenib in Hepatocellular Carcinoma Patients After Liver Transplantation
CLINICAL_TRIALS study record update · 2015-03-20
A Phase II Trial of Dasatinib (BMS-354825) in Advanced Hepatocellular Carcinoma
CLINICAL_TRIALS study record update · 2015-01-05
A Phase II Study of GW572016 (Lapatanib) in Locally Advanced or Metastatic Hepato-Biliary Cancers
CLINICAL_TRIALS study record update · 2014-12-02
Trans-Arterial Chemo-Embolization (TACE) vs TACE Plus Stereotactic Body Radio Therapy (SBRT) in the Treatment of Hepatocellular Carcinoma (HCC)
CLINICAL_TRIALS study record update · 2014-10-30
A Phase II Trial of Bortezomib Plus Doxorubicin in Hepatocellular Carcinoma
CLINICAL_TRIALS study record update · 2014-09-09
A Multicenter Phase II Study of the Combination of AZD6244 Hydrogen Sulfate and MK-2206 in Patients With Refractory Advanced Biliary Cancers
CLINICAL_TRIALS study record update · 2014-05-14
A Phase II Trial Of The Epothilone B Analog BMS-247550 (NSC 710428D) In Patients With Hepatobiliary Cancer
CLINICAL_TRIALS study record update · 2013-12-03
A Phase 2 Study of IMC-A12 (NSC742460) in Hepatocellular Carcinoma
CLINICAL_TRIALS study record update · 2013-09-30
A Phase I Study of UCN-01 in Combination With Irinotecan in Resistant Solid Tumor Malignancies (Part I) and in Triple Negative (ER-Negative, PgR-Negative, HER-2 Not-Amplified) Recurrent Breast Cancers (Part II)
CLINICAL_TRIALS study record update · 2013-07-10
Phase II Study of Bevacizumab Plus Erlotinib in Patients With Advanced Hepatocellular Cancer (HCC)
CLINICAL_TRIALS study record update · 2013-06-18
A Phase II Study of Oxaliplatin in Hepatocellular Cancer